☰

Hikaru Sasaki - Publications

Affiliations: 
Neurosurgery Keio University, Tokyo, Minato-ku, Tōkyō-to, Japan 
Area:
Chemotherapy, Brain Tumor
Website:
http://web.sc.itc.keio.ac.jp/ns/eng/ikyoku_eng/index_staff_eng.html
Tree Info Grants Similar researchers PubMed Report error

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Sasaki H. [Meningioma]. No Shinkei Geka. Neurological Surgery. 51: 829-836. PMID 37743334 DOI: 10.11477/mf.1436204824  0.401
2023 Tamura R, Iwanami A, Ohara K, Nishimoto M, Pareira ES, Miwa T, Tsuzaki N, Kuranari Y, Morimoto Y, Toda M, Okano H, Nakamura M, Yoshida K, Sasaki H. Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence. Brain Tumor Pathology. PMID 36892668 DOI: 10.1007/s10014-023-00453-w  0.373
2022 Pareira ES, Shibuya M, Ohara K, Nakagawa Y, Kanazawa T, Kamamoto D, Kato Y, Arai E, Aimono E, Yoshida K, Nishihara H, Kanai Y, Sasaki H. The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas. Brain Tumor Pathology. 39: 79-87. PMID 35292862 DOI: 10.1007/s10014-022-00426-5  0.362
2021 Kanazawa T, Ohara K, Kitamura Y, Nakaya M, Yoshida K, Sasaki H. Histopathological investigation of the 1p/19q-codeleted gliomas resected following alkylating agent chemotherapy. Journal of Neuro-Oncology. PMID 34718935 DOI: 10.1007/s11060-021-03855-y  0.383
2021 Kumon M, Nakae S, Murayama K, Kato T, Ohba S, Inamasu J, Yamada S, Abe M, Sasaki H, Ohno Y, Hasegawa M, Kurahashi H, Hirose Y. Myoinositol to Total Choline Ratio in Glioblastomas as a Potential Prognostic Factor in Preoperative Magnetic Resonance Spectroscopy. Neurologia Medico-Chirurgica. PMID 34078827 DOI: 10.2176/nmc.oa.2020-0312  0.311
2020 Arita H, Matsushita Y, Machida R, Yamasaki K, Hata N, Ohno M, Yamaguchi S, Sasayama T, Tanaka S, Higuchi F, Iuchi T, Saito K, Kanamori M, Matsuda KI, Miyake Y, ... ... Sasaki H, et al. TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations. Acta Neuropathologica Communications. 8: 201. PMID 33228806 DOI: 10.1186/s40478-020-01078-2  0.544
2019 Kanazawa T, Minami Y, Takahashi H, Fujiwara H, Toda M, Jinzaki M, Yoshida K, Sasaki H. Magnetic resonance imaging texture analyses in lower-grade gliomas with a commercially available software: correlation of apparent diffusion coefficient and T2 skewness with 1p/19q codeletion. Neurosurgical Review. PMID 31402410 DOI: 10.1007/s10143-019-01157-6  0.385
2019 Kuwahara K, Ohba S, Nakae S, Hattori N, Pareira ES, Yamada S, Sasaki H, Abe M, Hasegawa M, Hirose Y. Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II-III gliomas to establish genetic predictors of poor prognosis. Brain Tumor Pathology. PMID 31324999 DOI: 10.1007/s10014-019-00348-9  0.433
2019 Pareira E, Ohara K, Shibuya M, Nakagawa Y, Yoshida K, Sasaki H. PATH-58. REAPPRAISAL OF HISTOLOGICAL FEATURES AND MOLECULAR ANALYSIS OF LOWER GRADE GLIOMAS AND ASSOCIATION WITH OVERALL SURVIVALS Neuro-Oncology. 21: vi156-vi156. DOI: 10.1093/neuonc/noz175.653  0.42
2019 Arita H, Matsushita Y, Ohno M, Miyake Y, Saito K, Tanaka S, Nakamura T, Tamura K, Higuchi F, Sandika E, Sabit H, Hattori Y, Yamaguchi S, Okita Y, Sakamoto D, ... ... Sasaki H, et al. PATH-37. PROGNOSTIC ROLE OF TERT PROMOTER MUTATIONS IMPROVES THE STRATIFICATION OF IDH-MUTATED LOWER GRADE GLIOMA Neuro-Oncology. 21: vi151-vi151. DOI: 10.1093/neuonc/noz175.633  0.535
2018 Kayama T, Sato S, Sakurada K, Mizusawa J, Nishikawa R, Narita Y, Sumi M, Miyakita Y, Kumabe T, Sonoda Y, Arakawa Y, Miyamoto S, Beppu T, Sugiyama K, Nakamura H, ... ... Sasaki H, et al. Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018786186. PMID 29924704 DOI: 10.1200/JCO.2018.78.6186  0.408
2018 Kanazawa T, Fujiwara H, Takahashi H, Nishiyama Y, Hirose Y, Tanaka S, Yoshida K, Sasaki H. Imaging scoring systems for preoperative molecular diagnoses of lower-grade gliomas. Neurosurgical Review. PMID 29700705 DOI: 10.1007/s10143-018-0981-x  0.36
2017 Nakae S, Kato T, Murayama K, Sasaki H, Abe M, Kumon M, Kumai T, Yamashiro K, Inamasu J, Hasegawa M, Kurahashi H, Hirose Y. Remote intracranial recurrence of IDH mutant gliomas is associated with TP53 mutations and an 8q gain. Oncotarget. 8: 84729-84742. PMID 29156679 DOI: 10.18632/oncotarget.20951  0.443
2016 Hayashi S, Kitamura Y, Hirose Y, Yoshida K, Sasaki H. Molecular-genetic and clinicopathological prognostic factors in patients with gliomas showing total 1p19q loss: gain of chromosome 19p and histological grade III negatively correlate with patient's prognosis. Journal of Neuro-Oncology. PMID 28025770 DOI: 10.1007/s11060-016-2344-1  0.431
2016 Kitamura Y, Komori T, Shibuya M, Ohara K, Saito Y, Hayashi S, Sasaki A, Nakagawa E, Tomio R, Kakita A, Nakatsukasa M, Yoshida K, Sasaki H. Comprehensive Genetic Characterization of Rosette-Forming Glioneuronal Tumors: Independent Component Analysis by Tissue Microdissection. Brain Pathology (Zurich, Switzerland). PMID 27893178 DOI: 10.1111/Bpa.12468  0.322
2016 Nakae S, Murayama K, Sasaki H, Kumon M, Nishiyama Y, Ohba S, Adachi K, Nagahisa S, Hayashi T, Inamasu J, Abe M, Hasegawa M, Hirose Y. Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parameters. Journal of Neuro-Oncology. PMID 27837434 DOI: 10.1007/s11060-016-2313-8  0.301
2016 Hattori N, Hirose Y, Sasaki H, Nakae S, Hayashi S, Ohba S, Adachi K, Hayashi T, Nishiyama Y, Hasegawa M, Abe M. WHO grade II-III astrocytomas consist of genetically distinct tumor lineages. Cancer Science. PMID 27196377 DOI: 10.1111/cas.12969  0.494
2015 Nakae S, Sasaki H, Hayashi S, Hattori N, Kumon M, Nishiyama Y, Adachi K, Nagahisa S, Hayashi T, Inamasu J, Abe M, Hasegawa M, Hirose Y. PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas. Plos One. 10: e0142750. PMID 26558387 DOI: 10.1371/journal.pone.0142750  0.358
2015 Hayashi S, Sasaki H, Kimura T, Abe T, Nakamura T, Kitamura Y, Miwa T, Kameyama K, Hirose Y, Yoshida K. Molecular-genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort. Oncotarget. PMID 25991674  0.468
2014 Akimoto J, Sasaki H, Haraoka R, Nakajima N, Fukami S, Kohno M. Case of radiologically multicentric but genetically identical multiple glioblastomas. Brain Tumor Pathology. 31: 113-7. PMID 23934332 DOI: 10.1007/s10014-013-0157-x  0.325
2014 Hirose Y, Sasaki H. ASTROCYTIC TUMORS WITH GAIN ON 7Q AND THOSE WITH GAIN OF WHOLE CHROMOSOME 7 BELONG TO DISTINCT SUBGROUPS CHARACTERIZED BY VARIOUS GENETIC FACTORS INCLUDING IDH1 AND TP53 Neuro-Oncology. 16: iii9-iii9. DOI: 10.1093/NEUONC/NOU206.30  0.446
2013 Kitamura Y, Sasaki H, Kimura T, Miwa T, Takahashi S, Kawase T, Yoshida K. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis. Journal of Neuropathology and Experimental Neurology. 72: 816-23. PMID 23965741 DOI: 10.1097/NEN.0b013e3182a065d0  0.453
2013 Hirose Y, Sasaki H, Abe M, Hattori N, Adachi K, Nishiyama Y, Nagahisa S, Hayashi T, Hasegawa M, Yoshida K. Subgrouping of gliomas on the basis of genetic profiles. Brain Tumor Pathology. 30: 203-8. PMID 23604523 DOI: 10.1007/s10014-013-0148-y  0.443
2013 Kitamura Y, Akiyama T, Sasaki H, Hayashi Y, Yoshida K. Optic nerve seeding of atypical meningiomas presenting with subacute visual loss: 2 case reports with genetic characterization. Journal of Neurosurgery. 119: 494-8. PMID 23432529 DOI: 10.3171/2013.1.JNS121533  0.308
2013 Ishii T, Mizukawa K, Sasayama T, Sasaki H, Hayashi S, Nakamizo S, Tanaka H, Tanaka K, Hara S, Hirai C, Itoh T, Kohmura E. Immunohistochemical and molecular genetics study of a granular cell astrocytoma: a case report of malignant transformation to a glioblastoma. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 33: 299-305. PMID 22994265 DOI: 10.1111/j.1440-1789.2012.01349.x  0.341
2013 Sano K, Toda M, Sasaki H, Kitamura Y, Mikami S, Hirato J, Inoue S, Kawase T, Yoshida K. Infratentorial low-grade oligoastrocytoma with aggressive clinical behavior in an adult: a case report with genetic characterization. Brain Tumor Pathology. 30: 99-103. PMID 22752622 DOI: 10.1007/s10014-012-0111-3  0.419
2013 Adachi K, Sasaki H, Nagahisa S, Yoshida K, Hattori N, Nishiyama Y, Kawase T, Hasegawa M, Abe M, Hirose Y, Alentorn A, Marie Y, Poggioli S, Alshehhi H, Boisselier B, et al. OMICS AND PROGNSTIC MARKERS Neuro-Oncology. 15: iii136-iii155. DOI: 10.1093/Neuonc/Not183  0.51
2012 Kitamura Y, Sasaki H, Yoshida K. Molecular and genetic profiles of radiographically defined de novo meningiomas. Journal of Neuro-Oncology. 108: 37-44. PMID 22274402 DOI: 10.1007/s11060-012-0797-4  0.357
2011 Ohba S, Shimizu K, Shibao S, Miwa T, Nakagawa T, Sasaki H, Murakami H. A glioblastoma arising from the attached region where a meningioma had been totally removed. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 31: 606-11. PMID 21284750 DOI: 10.1111/j.1440-1789.2011.01198.x  0.412
2011 Miwa T, Hirose Y, Sasaki H, Ezaki T, Yoshida K, Kawase T. Single-copy gain of chromosome 1q is a negative prognostic marker in pediatric nonependymal, nonpilocytic gliomas. Neurosurgery. 68: 206-12. PMID 21099717 DOI: 10.1227/NEU.0b013e3181fd2c2e  0.435
2009 Miwa T, Hirose Y, Sasaki H, Ikeda E, Yoshida K, Kawase T. Genetic characterization of adult infratentorial gliomas. Journal of Neuro-Oncology. 91: 251-5. PMID 18941867 DOI: 10.1007/s11060-008-9714-2  0.442
2004 Megyesi JF, Kachur E, Lee DH, Zlatescu MC, Betensky RA, Forsyth PA, Okada Y, Sasaki H, Mizoguchi M, Louis DN, Cairncross JG. Imaging correlates of molecular signatures in oligodendrogliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 4303-6. PMID 15240515 DOI: 10.1158/1078-0432.Ccr-04-0209  0.649
2002 Hartmann C, Johnk L, Sasaki H, Jenkins RB, Louis DN. Novel PLA2G4C polymorphism as a molecular diagnostic assay for 19q loss in human gliomas. Brain Pathology (Zurich, Switzerland). 12: 178-82. PMID 11958371 DOI: 10.1111/J.1750-3639.2002.Tb00432.X  0.659
2002 Sasaki H, Betensky RA, Cairncross JG, Louis DN. DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis. Cancer Research. 62: 1790-6. PMID 11912156  0.601
2002 Sasaki H, Zlatescu MC, Betensky RA, Johnk LB, Cutone AN, Cairncross JG, Louis DN. Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma". Journal of Neuropathology and Experimental Neurology. 61: 58-63. PMID 11829344 DOI: 10.1093/Jnen/61.1.58  0.631
2001 Sasaki H, Zlatescu MC, Betensky RA, Ino Y, Cairncross JG, Louis DN. PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. The American Journal of Pathology. 159: 359-67. PMID 11438483 DOI: 10.1016/S0002-9440(10)61702-6  0.691
2000 Tortosa A, Ino Y, Odell N, Swilley S, Sasaki H, Louis DN, Henson JW. Molecular genetics of radiographically defined de novo glioblastoma multiforme. Neuropathology and Applied Neurobiology. 26: 544-52. PMID 11123721 DOI: 10.1046/J.0305-1846.2000.00290.X  0.613
2000 Ino Y, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Jhung S, Ramsay DA, von Deimling A, Louis DN, Cairncross JG. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. Journal of Neurosurgery. 92: 983-90. PMID 10839259 DOI: 10.3171/Jns.2000.92.6.0983  0.692
Show low-probability matches.